Intramuscular methotrexate-induced aseptic meningitis

Annals of Pharmacotherapy

Volumn 41, Issue 11, 2007, Pages 1906-1911

  Hawboldt, John ^a,b,c   Bader, Mazen ^a  

^a Health Sciences Centre   (Canada)

^b Eastern Health Canada   (Canada)

^c Health Sciences Centre St John's   (Canada)

Author keywords

Aseptic meningitis; Methotrexate; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ATENOLOL; CALCIUM CARBONATE; DILTIAZEM; ETANERCEPT; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; LEVOTHYROXINE; METHOTREXATE; PREDNISONE; RAMIPRIL; RANITIDINE; SIMVASTATIN;

ADULT; ARTICLE; ASEPTIC MENINGITIS; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MENINGITIS, ASEPTIC; METHOTREXATE; MIDDLE AGED;

EID: 35748974853     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K308     Document Type: Article

References (22)

1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-11.
2. Allaire SL, Prashker MJ, Meenan RF. The costs of rheumatoid arthritis. Pharmacoeconomics 1994;6:513-22.
3. Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology 2000;39:28-33.
4. Gaffo A, Saag KG, Curtis JR. Treatment of rheumatoid arthritis. Am J Health Syst Pharm 2006;63:2451-65.
5. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the Management of Rheumatoid Arthritis. Arthritis Rheum 2002;46:328-46.
6. Methotrexate. In: Repchinsky C, ed. Compendium of pharmaceuticals and specialities (CPS). Ottawa: Canadian Pharmaceutical Association, 2007:1431.
7. Methotrexate. Lexidrugs On-line. http://online.lexi.com/crlsql/servlet/ cr-lonline (accessed 2007 Mar 5).
8. Phillips PC. Methotrexate neurotoxicity. In: Rottenberg DA, ed. Neurological complications of cancer treatment. 1st ed. Stoneham, MA: Butterworth-Heinemann, 1991:115-30.
9. Kunzmann S, Warmuth-Metz M, Girschick HJ. Cerebral demyelination in association with TNF-inhibition therapy in a 5-year-old girl with aseptic meningitis as the first symptom of Still's disease. Scand J Rheum 2005;34:76-8.
10. Hopkins S, Jolies S. Drug-induced aseptic meningitis. Expert Opin Drug Saf 2005;4:285-97.
11. Marinac JS. Drug- and chemical-induced aseptic meningitis: a review of the literature. Ann Pharmacother 1992;26:813-22.
12. Jolles S, Sewell WA, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Saf 2000;22:215-26.
13. Geiser CF, Bishop Y, Jaffe N, et al. Adverse effects of intrathecal methotrexate in children with acute leukemia in remission. Blood 1975; 45:189-95.
14. Bleyer WA, Drake JC, Chabner BA. Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973;289:770-3.
15. Mott MG, Stevenson P, Wood CB. Methotrexate meningitis (letter). Lancet 1972;2:656.
16. Chaudhry VP, Marwa RK. Intrathecal methotrexate induced meningitis. Indian Pediatr 1979;16:87-9.
17. Vezmar S, Becker A, Bode U, et al. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 2003;49:92-104.
18. Papineau-Gall E, Lieberman P, eds. DRUGDEX system. Greenwood Village, CO: MICROMEDEX,
19. Qin D, Ma J, Xiao J, et al. Effect of brain irradiation on blood-CSF barrier permeability of chemotherapeutic agents. Am J Clin Oncol 1997;20: 263-5.
20. Glantz MJ, Cole BF, Recht L, et al. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 1998;16:1561-7.
21. Canadian Adverse Drug Reaction Monitoring Program (CADRM). CADRM Database. Ottawa, Ontario: Health Canada, 2006.
22. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.